Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7370655 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL7370658 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL7348679 | 0.78 | MEN1 (0.64) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL7372796 | 0.77 | CYP1A2 (0.62) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL13038637 | 0.74 | MEN1 (0.59) | CYP1A2CYP2C19MEN1KMT2AKEAP1 | |
| SCHEMBL2451043 | 0.73 | CYP1A2 (0.57) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL1410564 | 0.73 | KEAP1 (0.61) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL12648709 | 0.73 | CYP1A2 (0.61) | CYP1A2CYP2C19MEN1KMT2ACA2 | |
| SCHEMBL1411424 | 0.73 | KEAP1 (0.61) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 | |
| SCHEMBL2451041 | 0.73 | CYP1A2 (0.57) | CYP1A2CYP2C19MEN1KMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025046244-A1 | TLR3 BINDING BICYCLIC PEPTIDE LIGANDS | BICYCLETX LIMITED (GB) | 2025-03-06 | — | — | WO | claimed |
| CN-113598742-B | Atrial fibrillation classification model training method, atrial fibrillation identification method and atrial fibrillation classification model training system | 合肥工业大学 | 2024-03-22 | — | — | CN | claimed |
| CN-119272937-B | Optimized scheduling method for source network load storage integrated project | 国网山西省电力公司经济技术研究院 | 2025-06-24 | — | — | CN | disclosed |
| CN-120082540-A | Engineering protein glutaminase mutant and active secretion expression method thereof in pichia pastoris | 华南理工大学 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025079348-A1 | THERAPEUTIC DRUG FOR INFLAMMATORY DISEASES, AND SCREENING METHOD FOR THERAPEUTIC DRUG | 国立大学法人東北大学 | 2025-04-17 | — | — | WO | disclosed |
| WO-2025046244-A1 | TLR3 BINDING BICYCLIC PEPTIDE LIGANDS | BICYCLETX LIMITED (GB) | 2025-03-06 | — | — | WO | disclosed |
| CN-119371457-A | Novel photocatalytic-shearing carboxylic acid protecting group 2-nitro-phosphoryloxy benzyl compound and preparation method of amino acid derivative thereof | 西北工业大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-119350387-A | Novel photocatalytic-shearing carboxylic acid protecting group phosphoryloxy-4-coumarin methyl compound and preparation method of amino acid derivative thereof | 西北工业大学 | 2025-01-24 | — | — | CN | disclosed |
| CN-119272937-A | Optimized scheduling method for source network load storage integrated project | 国网山西省电力公司经济技术研究院 | 2025-01-07 | — | — | CN | disclosed |
| US-12065399-B2 | Arylsulfonamide derivatives | HOFFMANN-LA ROCHE INC. (US) | 2024-08-20 | — | — | US | disclosed |
| CN-114671912-B | Method for homogeneously synthesizing blue copper tripeptide with assistance of light shearing carrier | 西北工业大学 | 2024-05-14 | — | — | CN | disclosed |
| US-20230016093-A1 | PHYSIOLOGICAL WAVEFORM SUMMARIZING SYSTEMS, MONITORS, CONTROLLERS AND METHODS | KONINKLIJKE PHILIPS N.V. (NL) | 2023-01-19 | — | — | US | disclosed |
| US-11535852-B2 | Nucleic acid compounds for binding growth differentiation factor 11 | SOMALOGIC OPERATING CO., INC. (US) | 2022-12-27 | — | — | US | disclosed |
| CN-114805432-A | Novel photocatalytic-cleavable carboxylic acid protecting group and preparation method of amino acid derivative thereof | 西北工业大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-114671912-A | Method for homogeneous synthesis of blue copper tripeptide with assistance of photo-shearing carrier | 西北工业大学 | 2022-06-28 | — | — | CN | disclosed |
| EP-4013495-A1 | ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC MODULATORS | F. Hoffmann-La Roche AG (CH) | 2022-06-22 | — | — | EP | disclosed |
| US-20220169599-A1 | ARYLSULFONAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2022-06-02 | — | — | US | disclosed |
| US-20220088040-A1 | Use of System XC-Inhibitor for Treating Statin-Induced Myalgia | EXERKINE CORP (CA) | 2022-03-24 | — | — | US | disclosed |
| US-11274158-B2 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| CN-114174266-A | Arylsulfonamide derivatives as MGLUR4 negative allosteric modulators | 豪夫迈·罗氏有限公司 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535852-B2 | Nucleic acid compounds for binding growth differentiation factor 11 | MSTN, S100A11, IGF2BP1 | CYP1A2 4876/4885CYP2C19 4878/4885MEN1 1586/4885 |
| US-20220169599-A1 | ARYLSULFONAMIDE DERIVATIVES | ARSA, SULT1E1, STS | CYP1A2 95/4885CYP2C19 57/4885MEN1 2505/4885 |
| US-12065399-B2 | Arylsulfonamide derivatives | ARSA, SULT1E1, STS | CYP1A2 95/4885CYP2C19 57/4885MEN1 2505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.